Global Renal disease Market information, by type (Acute kidney problems, Chronic kidney diseases, and others), by Diagnosis (Blood tests, Urine tests, Imaging tests, Removing a sample of kidney tissue for testing, and others), by Treatment (Medications, Dialysis, Kidney transplant, Surgery, Diet and others) - Forecast to 2023
Market Synopsis of Global Renal disease Market:
Renal disease also known as kidney diseases that affects the functioning of kidneys. According to National Kidney Foundation, Inc., 10% of world’s population is suffering from chronic kidney diseases. Global Renal disease Market is growing moderately. The growing prevalence of renal diseases is leading the market growth. Increasing R&D activities and clinical trials are major driving forces of the market. Increasing acquaintance and awareness among the patients, growing healthcare sector, government initiatives and new product launches are key factors for the global renal disease market.
The Global Renal disease market is growing at the CAGR of ~6.3% during the forecast period and expected to reach US$ 14291.2 million by 2023.
Study objectives of Global Renal disease Market:
To provide detailed analysis of the Global Renal disease market structure with historical and forecasted revenue for the next 7 years of the various segments and sub-segments of the Renal disease Market
To provide insights about the key drivers, restraints, opportunities and challenges that affecting the growth of the Renal disease market
To provide analysis of the market with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
To provide detail analysis of the market that segmented on the basis of type, by diagnosis, by treatment, and its sub-segments.
To provide detail analysis of global renal disease market mainly based on Value chain analysis, Porter’s five forces, Price analysis, and Supply Chain analysis etc.
To provide detail country level analysis of the market with respect to the current market size and future prospective
To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Global Renal disease Market
To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the renal diseases market
Key Players for Global Renal disease Market:
Some of the key players in this market are: Abbott (US), Amgen Inc. (US), Baxter (US), Bristol-Myers Squibb Company (US), Keryx Biopharmaceuticals, Inc. (US), NephroGenex, Inc. (US), Novartis AG (Switzerland), Pfizer Inc.(US), Sanofi (France), Shire Pharmaceuticals Limited (Republic of Ireland), and others.
Global Renal disease Market has been segmented on the basis of type which comprise acute kidney problems (Prerenal, Postrenal, Renal), Chronic kidney diseases, and others. On the basis of diagnosis, it segmented into Blood Tests (Serum Creatinine, Glomerular Filtration Rate(GFR), Blood Urea Nitrogen (BUN), fasting blood glucose test), Urine test (Urinalysis, Protein urine test, Microalbuminuria test, Creatinine Clearance test), Imaging test (Ultrasound, CT Scan ), Removing a sample of kidney tissue for testing. On the basis of treatment, it segmented into medication (High blood pressure medications, Medications to lower cholesterol levels, Medications to treat anemia, Medications to relieve swelling, Medications to protect your bones), Dialysis (Hemodialysis, Peritoneal dialysis), kidney transplant (Deceased-donor kidney transplant, Living-donor kidney transplant, Pre-emptive kidney transplant ), surgery (Nephrectomy and radical nephrectomy, nephron-sparing surgery (NSS), nephrolithotripsy , Extracorporeal shock wave lithotripsy (ESWL), and others), diet and others.
Regional Analysis of Global Renal disease Market:
Considering the global scenario of the market, North America is believed to be the largest market for global renal disease. Moreover the European market is the second largest market for global renal disease and Western Europe region is the dominating the market in Europe. On the other hand, Asia-Pacific (APAC) is expected to grow at significant rate in the global renal disease market during the forecast period. Middle East and Africa (ME&A) is likely to have a limited growth in the market due to less awareness of disease and treatment.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/3167
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Phone: +1 646 845 9312
Email: [email protected]